[Prostaglandin and nociceptin/orphanin FQ].
Minami
Toshiaki
T
Okuda-Ashitaka
Emiko
E
Ito
Seiji
S
D000634:Aminoquinolines / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D016718:Arachidonic Acid / Q000378:metabolism; D001549:Benzamides / Q000494:pharmacology / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors; D015237:Dinoprost / Q000096:biosynthesis / Q000502:physiology*; D015232:Dinoprostone / Q000096:biosynthesis / Q000502:physiology*; D006801:Humans; D009292:Narcotic Antagonists; D009437:Neuralgia / Q000188:drug therapy* / Q000209:etiology*; D009569:Nitric Oxide / Q000502:physiology; D018847:Opioid Peptides / Q000502:physiology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology; D011957:Receptors, Opioid; D013116:Spinal Cord; D000094942:Nociceptin Receptor; D000097629:Nociceptin
D000634:Aminoquinolines; D000894:Anti-Inflammatory Agents, Non-Steroidal; D016718:Arachidonic Acid; D001549:Benzamides; D016861:Cyclooxygenase Inhibitors; D015237:Dinoprost; D015232:Dinoprostone; D009292:Narcotic Antagonists; D009569:Nitric Oxide; D018847:Opioid Peptides; D016194:Receptors, N-Methyl-D-Aspartate; D011957:Receptors, Opioid; D000094942:Nociceptin Receptor; D000097629:Nociceptin; C433236:N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide; C000722283:OPRL1 protein, human